ROLE OF BASELINE INFLAMMATORY MARKERS IN PREDICTING EARLY RESPONSE AND REMISSION TO VEDOLIZUMAB

(1) Royal Liverpool University Hospital, Gastroenterology, Liverpool, United Kingdom

(2) University of Liverpool, Unit of Gastroenterology Research, Liverpool, United Kingdom

(3) University of Liverpool, Dept of Translational medicine, Liverpool, United Kingdom

(4) Royal Liverpool University Hospital, Liverpool, United Kingdom



This item was part of UEG Week 2016

This item can be cited as: United European Gastroenterology Journal; 2016: 2 (Supplement 1)